Literature DB >> 27746959

Fine-tuning treatment for patients with ST-elevation myocardial infarction.

Feng Qian1, Edward L Hannan1.   

Abstract

Entities:  

Year:  2016        PMID： 27746959      PMCID： PMC5059330          DOI： 10.21037/jtd.2016.08.11

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  24 in total

1.  Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry).

Authors:  Artur Dziewierz; Zbigniew Siudak; Tomasz Rakowski; Wojciech Zasada; Jacek S Dubiel; Dariusz Dudek
Journal:  Am J Cardiol       Date:  2010-06-18       Impact factor: 2.778

2.  Is Aspiration Thrombectomy Beneficial in Patients Undergoing Primary Percutaneous Coronary Intervention? Meta-Analysis of Randomized Trials.

Authors:  Islam Y Elgendy; Tianyao Huo; Deepak L Bhatt; Anthony A Bavry
Journal:  Circ Cardiovasc Interv       Date:  2015-07       Impact factor: 6.546

3.  The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Alice K Jacobs; Jeffrey L Anderson; Jonathan L Halperin
Journal:  J Am Coll Cardiol       Date:  2014-08-04       Impact factor: 24.094

4.  Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction.

Authors:  Argyrios Ntalianis; Jan-Willem Sels; Giedrius Davidavicius; Nobuhiro Tanaka; Olivier Muller; Catalina Trana; Emanuele Barbato; Michalis Hamilos; Fabio Mangiacapra; Guy R Heyndrickx; William Wijns; Nico H J Pijls; Bernard De Bruyne
Journal:  JACC Cardiovasc Interv       Date:  2010-12       Impact factor: 11.195

5.  Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon.

Authors:  Hon-Kan Yip; Mien-Cheng Chen; Hsueh-Wen Chang; Chi-Ling Hang; Yuan-Kai Hsieh; Chih-Yuan Fang; Chiung-Jen Wu
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

6.  Multiple complex coronary plaques in patients with acute myocardial infarction.

Authors:  J A Goldstein; D Demetriou; C L Grines; M Pica; M Shoukfeh; W W O'Neill
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

7.  Outcomes 1 year after thrombus aspiration for myocardial infarction.

Authors:  Bo Lagerqvist; Ole Fröbert; Göran K Olivecrona; Thórarinn Gudnason; Michael Maeng; Patrik Alström; Jonas Andersson; Fredrik Calais; Jörg Carlsson; Olov Collste; Matthias Götberg; Peter Hårdhammar; Dan Ioanes; Anders Kallryd; Rickard Linder; Anders Lundin; Jacob Odenstedt; Elmir Omerovic; Verner Puskar; Tim Tödt; Eva Zelleroth; Ollie Östlund; Stefan K James
Journal:  N Engl J Med       Date:  2014-09-01       Impact factor: 91.245

8.  Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.

Authors:  Paul Sorajja; Bernard J Gersh; David A Cox; Michael G McLaughlin; Peter Zimetbaum; Costantino Costantini; Thomas Stuckey; James E Tcheng; Roxana Mehran; Alexandra J Lansky; Cindy L Grines; Gregg W Stone
Journal:  Eur Heart J       Date:  2007-06-07       Impact factor: 29.983

9.  Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden.

Authors:  Georgios Sianos; Michail I Papafaklis; Joost Daemen; Sofia Vaina; Carlos A van Mieghem; Ron T van Domburg; Lampros K Michalis; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2007-07-30       Impact factor: 24.094

10.  Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.

Authors:  Anthony H Gershlick; Jamal Nasir Khan; Damian J Kelly; John P Greenwood; Thiagarajah Sasikaran; Nick Curzen; Daniel J Blackman; Miles Dalby; Kathryn L Fairbrother; Winston Banya; Duolao Wang; Marcus Flather; Simon L Hetherington; Andrew D Kelion; Suneel Talwar; Mark Gunning; Roger Hall; Howard Swanton; Gerry P McCann
Journal:  J Am Coll Cardiol       Date:  2015-03-17       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.